iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
This trial is active, not recruiting.
|Conditions||end-stage kidney disease, kidney failure, chronic, kidney transplantation|
|Treatment||ichoose kidney decision aid|
|Start date||September 2014|
|End date||November 2015|
|Trial size||450 participants|
|Trial identifier||NCT02235571, IRB00076067|
The investigators developed iChoose Kidney -- a shared decision-making support tool accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers with a simple, standardized, easily accessible, statistically robust tool for use in the clinic to guide patient education and healthcare decision-making about treatment options of dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with estimates of their individualized 1 and 3-year risks of mortality on dialysis vs. transplantation, based on previous national data. The tool has the potential to improve communication and decision-making between patients and their healthcare providers and improve access to kidney transplantation among patients with ESRD.
This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers with diverse patient populations. One group of patients will receive standard education alone during their scheduled transplant evaluation. The second group will receive the standard education as well have the provider use the iChoose Kidney aid with them. The project timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and outcome evaluation.
This study will assess how well the iChoose decision aid works in improving patient knowledge, preferences for treatment, and patient access to transplant. The study will also assess whether providers find the tool useful for providing ways to share information with patients about ways to treat their kidney disease.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Atlanta, GA||Emory Transplant Center||no longer recruiting|
|Chicago, IL||Northwestern University (Kovler Transplant Center)||no longer recruiting|
|New York, NY||Columbia University Medical Center||no longer recruiting|
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
Effectiveness of the iChoose Kidney intervention to improve knowledge and shared decision-making between patients and physicians regarding ESRD treatment options.
time frame: Up to 19 months
Patient access to transplant
time frame: Up to 19 months
Male or female participants at least 18 years old.
Inclusion Criteria: - Diagnosis of end-stage renal disease (ESRD) and on dialysis for < 1 year - English-speaking - Subjects coming in for transplant medical evaluation - Age > 18 years Exclusion Criteria: - Severe cognitive or visual impairment
|Official title||iChoose Kidney Decision Aid for Treatment Options Among End-Stage Renal Disease (ESRD) Patients|
|Principal investigator||Rachel Patzer, PhD, MPH|
Call for more information